Annual Report

Overview

The report describes a strong FY24, including revenues of ₹ 582.1 crores and continued growth across the company's pharmaceutical businesses. It reports a 27% reduction in carbon emissions, alongside 16% lower water consumption, 49% lower waste generation, and 26% improved energy efficiency. The report also records 1,142 employees and highlights community initiatives covering education, employability, healthcare clinics, and heritage preservation.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2023-2024
Period: Ends 31 March 2024
Language: English
Pages
File size

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services